Mar 07, 2022 / 07:10PM GMT
Yaron Benjamin Werber - Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
Well, good afternoon, everybody, and thank you once again for joining us for the 42nd Annual Cowen Healthcare Conference. It's a great pleasure to moderate the fireside chat today with argenx. I'm Yaron Werber, one of the biotech analysts here at Cowen, and I'm with my colleague, Brendan Smith, also on our team.
So it's a great pleasure to have with us, and they all need no introduction. Tim Van Hauwermeiren, who's the CEO of argenx; Keith Woods, Chief Operating Officer; and Karl Gubitz, who is the Chief Financial Officer.
So gentlemen, thank you for joining us. We appreciate it.
Timothy Van Hauwermeiren - argenx SE - CEO & Executive Director
Thanks for having us, Yaron. As always, it's a pleasure.
Questions and Answers:
Yaron Benjamin Werber - Cowen and Company, LLC, Research Division - MD & Senior Biotechnology AnalystSo we have a lot to talk about. So Tim, I know you've been
Trustpilot
